Achievement Highlights

The Department of Medicine, School of Clinical Medicine is at the frontier of the discovery of cutting-edge medical research findings. Our academics are recognized globally for their research contribution, having published influential publications with high-impact factors.

International Recognition

Highly Cited Researchers (by Clarivate Analytics)


Two scholars from the Department of Medicine, School of Clinical Medicine have been named on the list of Highly Cited Researchers 2024:



This annual list by Clarivate Analytics recognizes researchers whose publications rank among the top 1% globally in terms of citations over the past decade. It serves as a testament to their significant impact within the academic community.


A full list of HKU Highly Cited Researchers 2024 can be found here.


 

World’s Top 2% Scientists (by Stanford University)


Twenty-seven scholars from the Department of Medicine, School of Clinical Medicine are ranked as the World’s Top 2% scientists in 2024 by Stanford University. The ranking was based on the "Updated science-wide author databases of standardized citation indicators", encompassing various factors such as citations, individual's research output, co-authorship and a composite indicator for career-long citation impact.



This prestigious acknowledgement reaffirms our world-class research standards and highlights the international recognition received by our researchers.


Click here for a complete list of the World’s Top 2% scientists 2024.

 

*Honorary Professoriate

 

Recent Impact Publications
2024

Year  Authors & Articles Impact Factor
2024 ALT to qHBsAg Ratio Predicts Long-term HBsAg Seroclearance after Entecavir Cessation in Chinese Patients with Chronic Hepatitis B
Leung, R.H.M.*, Hui, R.W.H.*, Mak, L.Y., Mao, X.H., Liu, K.S.H., Wong, D.K.H., Fung, J., Seto, W.K.** & Yuen, M.F.** Journal of Hepatology, 81(2), 218-226.
26.8
2024 Benefit and Harm of Aspirin on Mortality from Gastrointestinal Cancers vs Bleeding in Helicobacter pylori-Eradicated Patients
Cheung, K.S.*, Li, B.F., Wong, I.Y.H., Law, S. & Leung, W.K.** Clinical Gastroenterology and Hepatology, 22(9), 1810-1820.
11.6
2024 Cost-Effectiveness of Biosimilars vs Leflunomide in Patients with Rheumatoid Arthritis
Peng, K., Chan, S.C.W., Wang, Y., Cheng, F.W.T., Yeung, W.W.Y., Jiao, Y.S., Chan, E.W.Y., Wong, I.C.K., Lau, C.S. & Li, X.** JAMA Network Open, 7(6), e2418800.
10.5
2024 Early Renal Dysfunction in Middle-Aged Adults Predicts Fatal and Nonfatal Cardiovascular Events
Chan, Y.H.*, Zhao, J.V., Yeung, S.L.A., Wong, Y.K., Au, K.W., Xu, A.M., Lam, T.H., Cheung, B.M.Y., Lam, K.S.L. & Tse, H.F.** Journal of the American College of Cardiology, 83(25), 2711-2713.
21.7
2024 Effects of Empagliflozin on Liver Fat in Metabolic-Dysfunction Associated Steatotic Liver Disease Patients Without Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled Trial
Cheung, K.S.*, Ng, H.Y., Hui, W.H., Lam, L.K., Mak, L.Y., Ho, Y.C., Tan, J.T., Chan, W., Seto, W.K., Yuen, M.F. & Leung, W.K.** Hepatology, 80(4), 916-927.
14.0
2024 Endocuff With or Without Artificial Intelligence-Assisted Colonoscopy in Detection of Colorectal Adenoma: A Randomized Colonoscopy Trial
Lui, K.L.*, Lam, P.M., To, W.P., Ko, K.L., Tsui, W.M., Liu, S.H., Hui, K.Y., Cheung, K.S., Mak, L.Y., Hui, W.H., Wong, S.Y., Seto, W.K. & Leung, W.K.** The American Journal of Gastroenterology, 119(7), 1318-1325.
10.2
2024 Impact of a Drug Allergy Education Course for Non-Specialists: Findings from ADAPT-A Randomized Crossover Trial
Lucas, M., Mak, H.W.F., Lee, J.T.Y., Kulkarni, R., Chan, S.S.C. & Li, P.H.** Allergy. Online ahead of print.
12.6
2024 Long Non-coding RNA NEAT1, NOD-Like Receptor Family Protein 3 Inflammasome, and Acute Kidney Injury
Xue, R., Yiu, W.H., Chan, K.W., Lok, S.W.Y., Zou, Y.X., Ma, J.Y., Li, H.Y., Chan, L.Y.Y., Huang, X.R., Lai, K.N., Lan, H.Y. & Tang, S.C.W.** Journal of the American Society of Nephrology, 35(8), 998-1015.
10.3
2024

Optimal Glycaemic Control and the Reduced Risk of Colorectal Adenoma and Cancer in Patients with Diabetes: A Population-Based Cohort Study
Mao, X.H., Cheung, K.S.**, Tan, J.T., Mak, L.Y., Lee, C.H., Chiang, C.L., Cheng, H.M., Hui, R.W.H., Yuen, M.F., Leung, W.K. & Seto, W.K.** Gut, 73(8), 1313-1320.

23.0
2024 Risk of Acute Kidney Injury in Critically-ill Patients with COVID-19 Compared with Seasonal Influenza: A Retrospective Cohort Study
Ng, Y., Ip, A., Ng, K.Y., Sin, W.C., Chan, F.W., To, K.W. & Yap, Y.H.** eClinicalMedicine, 70, 102535.
15.1
2024 Virological Response to Nucleos(t)ide Analogues Treatment in Chronic Hepatitis B Patients is Associated with Bacteroides-dominant Gut Microbiome
Zhang, S.S.*, Chau, H.T., Tun, H.M., Huang, F.Y., Wong, D.K.H., Mak, L.Y., Yuen, M.F.** & Seto, W.K.** eBioMedicine, 103, 105101.
11.1
* Staff member as first author
** Staff member as corresponding author


2023

Year  Authors & Articles Impact Factor
2023 A Phase I/II Study of ARO-HSD, an RNA Interference Therapeutic, for the Treatment of Non-Alcoholic Steatohepatitis
Mak, L.Y.*, Gane, E., Schwabe, C., Yoon, K.T., Heo, J., Scott, R., Lee, J.H., Lee, J.I., Kweon, Y.O., Weltman, M., Harrison, S.A., Neuschwander-Tetri, B.A., Cusi, K., Loomba, R., Given, B.D., Christianson, D.R., Garcia-Medel, E., Yi, M., Hamilton, J. & Yuen, M.F.** Journal of Hepatology, 78(4), 684-692.
30.1
2023 Analysis of All-Cause Hospitalization and Death Among Nonhospitalized Patients with Type 2 Diabetes and SARS-CoV-2 Infection Treated with Molnupiravir or Nirmatrelvir-Ritonavir During the Omicron Wave in Hong Kong
Lui, D.T.W.*, Chung, M.S.H., Lau, E.H.Y., Lau, K.T.K., Au, I.C.H., Lee, C.H., Woo, Y.C., Wong, C.K.H. & Cowling, B.J. JAMA Network Open, 6(5), e2314393.
13.4
2023 Cardiovascular Risk in Rheumatoid Arthritis Patients Treated with Targeted Synthetic and Biological Disease-Modifying Antirheumatic Drugs: A Multi-Centre Cohort Study
Tong, X.N., Shen, C.Y., Jeon, H., Li, Y.H., Shin, J.Y., Chan, S.C., Yiu, K.H., Pratt, N.L., Ward, M., Lau, C.S., Wong, I.C., Li, X.** & Lai, E.C.C. Journal of Internal Medicine, 294(3), 314-325.
13.1
2023 Comparative Effectiveness, Safety, and Real-World Outcomes of a Nurse-Led, Protocol-Driven Penicillin Allergy Evaluation from the Hong Kong Drug Allergy Delabelling Initiative (HK-DADI)
Kan, A.K.C.*, Hui, H.K.S., Li, T.S., Chiang, V., Wong, J.C.Y., Chan, T.S., Kwan, I.Y.K., Shum, W.Z., Yeung, M.S.C., Au, E.Y.L., Ho, C.T.K., Lau, C.S. & Li, P.H.** Journal of Allergy and Clinical Immunology: In Practice, 11(2), 474-480.
11.0
2023 Epidemiology, Management, and Treatment Access of Hereditary Angioedema in the Asia Pacific Region: Outcomes from an International Survey
Li, P.H.*, Pawankar, R., Thong, B.Y.H., Fok, J.S., Chantaphakul, H., Hide, M., Jindal, A.K., Kang, H.R., Latiff, A.H.A., Lobo, R.C.M., Munkhbayarlakh, S., Nguyen, D.V., Shyur, S.D., Zhi, Y.X. & Maurer, M. Journal of Allergy and Clinical Immunology: In Practice, 11(4):1253-1260.
11.0
2023 Fibroblastic Reticular Cells in Lymph Node Potentiate White Adipose Tissue Beiging Through Neuro-Immune Crosstalk in Male Mice
Cheong, L.Y.*, Wang, B.L.*, Wang, Q., Jin, L.G., Kwok, K.H.M., Wu, X.P., Shu, L.L., Lin, H.G., Chung, S.K., Cheng, K.K.Y., Hoo, R.L.C. & Xu, A.M.** Nature Communications, 14(1), 1213.
 17.7
2023 Global Prevalence of Helicobacter Pylori Infection Between 1980 And 2022: A Systematic Review and Meta-Analysis
Li, Y.H., Choi, H., Leung, K., Jiang, F., Graham, D.Y. & Leung, W.K.** Lancet Gastroenterology & Hepatology, 8(6), 553-564.
45.0
2023 Glycemic Burden and The Risk of Adverse Hepatic Outcomes in Patients with Chronic Hepatitis B with Type 2 Diabetes
Mak, L.Y.*, Hui, R.W.H., Lee, C.H., Mao, X.H., Cheung, K.S., Wong, D.K.H., Lui, D.T.W., Fung, J., Yuen, M.F.** & Seto, W.K.** Hepatology, 77(2):606-618. 
17.3
2023
Hepatitis B Virus Pre-genomic RNA and Hepatitis B Core-related Antigen Reductions at Week 4 Predict Favourable Hepatitis B Surface Antigen Response upon Long-term Nucleos(t)ide Analogue in Chronic Hepatitis B
Mak, L.Y.*, Wong, D.*, Kuchta, A., Hilfiker, M., Hamilton, A., Chow, N., Mao, X.H., Seto, W.K. & Yuen, M.F.** Clinical and Molecular Hepatology, 29(1), 146-162.
14.0
2023
Incidence of Diabetes Following COVID-19 Vaccination and SARS-CoV-2 Infection in Hong Kong: A Population-Based Cohort Study
Xiong, X., Lui, T.W.*, Chung, S.H., Au, C.H., Lai, T.T., Wan, Y.F., Chui, S.L., Li, X., Cheng, W.T., Cheung, C.L., Chan, W.Y., Lee, C.H., Woo, Y.C., Tan, C.B., Wong, K.H. & Wong, C.K. PLoS Medicine, 20(7), e1004274.
15.8
2023
Inhibition of PLK4 Remodels Histone Methylation and Activates the Immune Response via the cGAS-STING Pathway in TP53-mutated AML
Man, C.H., Lam, W., Dang, C.C., Zeng, X.Y., Zheng, L.C., Chan, N.M., Ng, K.L., Chan, K.C., Kwok, T.H., Ng, C.C., Leung, W.Y., Huen, S.Y., Wong, C.L., So, C.W., Dou, Z., Goyama, S., Bray, M.R., Mak, T.W. & Leung, Y.H.** Blood, 142(23), 2002-2015. 
20.3
2023
Prediabetes is Associated with Increased Risk of Heart Failure Among Patients with Atrial Fibrillation
Huang, J.Y., Tse, Y.K., Li, H.L., Chen, C., Zhao, C.T., Liu, M.Y., Wu, M.Z., Ren, Q.W., Yu, S.Y., Hung, D., Li, X.L., Tse, H.F., Lip, G.Y.H. & Yiu, K.H.** Diabetes Care, 46(1), 190-196.
17.2
2023
Recapitulating Primary Immunodeficiencies with Expanded Potential Stem Cells: Proof of Concept with STAT1 Gain of Function
Liu, X., Chan, S.F., Smith, G.C., Ming, C., Or, C.S., Tsui, T.W., Gao, B., Cook, C., Liu, P., Lau, C.S. & Li, H.** The Journal of Allergy and Clinical Immunology, 153(4), 1125-1139. 
14.2
2023
Risk of Autoimmune Diseases Following COVID-19 and the Potential Protective Effect from Vaccination: A Population-Based Cohort Study
Peng, K., Li, X.**, Yang, D., Chan, C.W., Zhou, J., Wan, Y.F., Chui, S.L., Lai, T.T., Wong, K.H., Chan, W.Y., Leung, W.K., Lau, C.S. & Wong, C.K. eClinicalMedicine, 63, 102154.
15.1
2023 Risk of Postcolonoscopy Thromboembolic Events: A Real-World Cohort Study
Li, Y.K., Guo, C.G., Cheung, K.S., Liu, K.S.H. & Leung, W.K.** Clinical Gastroenterology and Hepatology, 21(12), 3051-3059.
13.6
2023

SGLT2i Reduces Risk of Developing HCC in Patients with Co-Existing Type 2 Diabetes and Hepatitis B Infection: A Territory-Wide Cohort Study in Hong Kong
Lee, C.H.*, Mak, L.Y.*, Tang, E.H.M., Lui, D.T.W., Mak, J.H.C., Li, L.L., Wu, T.T., Chan, W.L., Yuen, M.F., Lam, K.S.L. & Wong, C.K.H. Hepatology, 78(5), 1569-1580.

17.3
2023
Single-cell Transcriptomic Analysis Uncovers Intratumoral Heterogeneity and Drug-Tolerant Persister in ALK-Rearranged Lung Adenocarcinoma
Kwok, H.H., Li, H., Yang, J., Deng, J., Lee, C.M., Au, W.K., Sit, K.Y., Hsin, K.Y., Ma, K.Y., Cheung, W.T., Girard, L., Fujimoto, J., Wistuba, I.I., Gao, B., Minna, J.D. & Lam, C.L.** Cancer Communications, 43(8), 951-955.
16.2
2023

TLR7 Agonist RO7020531 versus Placebo in Healthy Volunteers and Patients with Chronic Hepatitis B Virus Infection: A Randomised, Observer-Blind, Placebo-Controlled, Phase 1 Trial
Yuen, M.F.*, Balabanska, R., Cottreel, E., Chen, E.T., Duan, D., Jiang, Q.D., Patil, A., Triyatni, M., Upmanyu, R., Zhu, Y.H., Canducci, F. & Gane, E.J. Lancet Infectious Diseases, 23(4), 496-507.

71.4
* Staff member as first author
** Staff member as corresponding author


2022

Year  Authors & Articles Impact Factor
2022 Autoimmune Conditions Following mRNA (BNT162b2) and Inactivated (CoronaVac) COVID-19 Vaccination: A Descriptive Cohort Study among 1.1 million Vaccinated People in Hong Kong
Li, X.*, Gao, L., Tong, X., Chan, K.Y., Chui, S.L., Lai, T.T., Wong, K.H., Wan, Y.F., Chan, W.Y., Lau, K.K., Lau, C.S. & Wong, C.K. Journal of Autoimmunity, 130, 102830.
12.8
2022 β-Klotho Promotes Glycolysis and Glucose-Stimulated Insulin Secretion via GP130
Geng, L.L.*, Liao, B.Y., Jin, L.G., Yu, J.S., Zhao, X.Y., Zhao, Y.T., Zhong, L., Wang, B.L., Li, J.F., Liu, J., Yang, J.K., Jia, W., Lian, Q.Z. & Xu, A.M.** Nature Metabolism, 4(5), 608-626.
20.0
2022
Cost-effectiveness of Universal Screening for Chronic Hepatitis B Virus Infection in China: An Economic Evaluation
Su, S., Wong, W.C., Zou, Z.R., Cheng, D.D., Ong, J.J., Chan, P.L., Ji, F.P., Yuen, M.F., Zhuang, G.H., Seto, W.K.** & Zhang, L. Lancet Global Health, 10(2), e278-e287.
39.0
2022
Early Treatment of High-risk Hospitalized Coronavirus Disease 2019 (COVID-19) Patients with A Combination of Interferon Beta-1b and Remdesivir: A Phase 2 Open-label Randomized Controlled Trial
Tam, A.R., Zhang, R., Lung, K.C., Liu, R., Leung, K.Y., Liu, D., Fan, Y., Lu, L., Lam, H.Y., Chung, W.H., Yip, C.Y., Lo, J., Wu, K.L., Lee, R., Sin, S., Ng, Y., Chan, W.M., Shum, H.P., Yan, W.W., Chan, F.W., Cheng, C.C., Lau, C.S., To, K.W., Chan, K.H., Yuen, K.Y. & Hung, F.N.** Clinical Infectious Diseases, 76(3), e216-e226.
11.8
2022
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection
Yuen, M.F.*, Lim, S.G., Plesniak, R., Tsuji, K., Janssen, H.L.A., Pojoga, C., Gadano, A., Popescu, C.P., Stepanova, T., Asselah, T., Diaconescu, G., Yim, H.J., Heo, J., Janczewska, E., Wong, A., Idriz, N., Imamura, M., Rizzardini, G., Takaguchi, K., Andreone, P., Arbune, M., Hou, J.L., Park, S.J., Vata, A., Cremer, J., Elston, R., Lukic, T., Quinn, G., Maynard, L., Kendrick, S., Plein, H., Campbell, F., Paff, M., Theodore, D. & B-Clear Study Group. New England Journal of Medicine, 387(21), 1957-1968.
176.1
2022
Evaluation of Fracture Risk Among Patients with Type 2 Diabetes and Nonvalvular Atrial Fibrillation Receiving Different Oral Anticoagulants
Lui, D.T.W.*, Tang, E.H.M., Au, I.C.H., Wu, T.T., Lee, C.H., Wong, C.K., Cheung, C.Y.Y., Fong, C.H.Y., Chow, W.S., Woo, Y.C., Tan, K.C.B., Lam, K.S.L. & Wong, C.K.H. Diabetes Care, 45(11), 2620-2627.
17.2
2022
FGF21-Srtuin 3 Axis Confers the Protective Effects of Exercise Against Diabetic Cardiomyopathy by Governing Mitochondrial Integrity
Jin, L.G.*, Geng, L.L.*, Ying, L., Shu, L.L., Ye, K., Yang, R.Y., Liu, Y., Wang, Y., Cai, Y., Jiang, X., Wang, Q., Yan, X.Q., Liao, B.Y., Liu, J., Duan, F.Y., Sweeney, G., Woo, C.W.H., Wang, Y., Xia, Z.Y., Lian, Q.Z. & Xu, A.M.** Circulation, 146(20), 1537-1557.
40.0
2022
Kidney Outcomes Associated with Sodium-Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists: A Real-World Population-Based Analysis
Lui, D.T.W.*, Au, I.C.H., Tang, E.H.M., Cheung, C.L., Lee, C.H., Woo, Y.C., Wu, T.T., Tan, K.C.B. & Wong, C.K.H. eClinicalMedicine, 50, 101510 
17.0
2022
Prognosis of Myocarditis Developing After mRNA COVID-19 Vaccination Compared with Viral Myocarditis
Lai, F.T.T., Chan, E.W.W., Huang, L., Cheung, C.L., Chui, C.S.L., Li, X., Wan, E.Y.F., Wong, C.K.H., Chan, E.W.Y., Yiu, K.H.** & Wong, I.C.K. Journal of the American College of Cardiology, 80(24), 2255-2265.
27.2
2022
Prospective Study on the Efficacy and Impact of Cascade Screening and Evaluation of Hereditary Angioedema (CaSE-HAE)
Wong, J.C.Y., Chiang, V., Lam, K., Tung, E., Au, E.Y.L., Lau, C.S. & Li, P.H.** Journal of Allergy and Clinical Immunology: In Practice, 10(11), 2896-2903.
11.0
2022
Regulation of Proton Partitioning in Kinase-Activating Acute Myeloid Leukemia and Its Therapeutic Implication
Man, C.H., Zeng, X.Y., Lam, W., Ng, T.C.C., Kwok, T.H., Dang, K.C.C., Leung, T.W.Y., Ng, N.K.L., Lam, S.S.Y., Cher, C.Y. & Leung, A.Y.H.** Leukemia, 36(8), 1990-2001.
13.0
2022
Risk of Thyroid Dysfunction Associated with mRNA and Inactivated COVID-19 Vaccines: A Population-Based Study of 2.3 million Vaccine Recipients
Wong, C.K.H., Lui, D.T.W.*, Xiong, X., Chui, C.S.L., Lai, F.T.T., Li, X., Wan, E.Y.F., Cheung, C.L., Lee, C.H., Woo, Y.C., Au, I.C.H., Chung, M.S.H., Cheng, F.W.T., Tan, K.C.B. & Wong, I.C.K. BMC Medicine, 20(1), 339.
11.8
2022
Two-dose COVID-19 Vaccination and Possible Arthritis Flare Among Patients with Rheumatoid Arthritis in Hong Kong
Li, X.*, Tong, X.N., Yeung, W.W.Y., Kuan, P., Yum, S.H.H., Chui, C.S.L., Lai, F.T.T., Wan, E.Y.F., Wong, C.K.H., Chan, E.W.Y., Lau, C.S. & Wong, I.C.K. Annals of the Rheumatic Diseases, 81(4), 564-568.
28.0
* Staff member as first author
** Staff member as corresponding author